Topcon Medical Systems has introduced a new computerized lensmeter (CL-300 Computerized Lensmeter) in U.S and Latin American markets.
Ophthalmology Times Staff Reports
Cerebral damage, not retinopathy of prematurity (ROP), may be the primary risk factor for visual impairment in preschool children who were born extremely prematurely, according to a Danish study published online in the Archives of Ophthalmology.
The hazards to the eyes of ultraviolet (UV) radiation are well known to eye-care professionals, but it’s possible they’re not conveying the need for UV protection strongly enough to their patients.
Abbott Medical Optics (AMO) has announced an impending change in leadership with the expected retirement of James V. Mazzo, president and chief executive officer (CEO), by the end of this year. Mazzo will be succeeded by Murthy Simhambhatla, PhD, who currently heads the Ibis Biosciences division of AMO’s parent company, Abbott Laboratories.
Smartphones can be a big help to the visually impaired, but few eye-care professionals (ECPs) are recommending them to patients, according to the results of a study presented at this year’s annual meeting of the Association for Research in Vision and Ophthalmology.
Avalanche Biotechnologies Inc. and Lonza have announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy.
Bioptigen has received 510(k) clearance from the FDA to begin marketing its hand-held spectral-domain optical coherence tomography (OCT) device (Envisu) for use in patients.
The Burke Medical Research Institute has been awarded a 5-year, $2,262,500 scientific research grant by the National Eye Institute of the National Institutes of Health.
Nidek has received FDA 510(k) clearance for a non-mydriatic automated fundus camera (AFC-330) that it will market to the U.S. ophthalmology market and Marco Ophthalmic will market to the optometry market.
The Pediatric Cataract Initiative (PCI) has awarded two research grants of $50,000 each, for projects by ORBIS in South Africa and Zambia and The International Centre for Eye Health (ICEH) in Bangladesh, for their work to reduce the prevalence of childhood blindness.